Financial News

Lonza’s Business Performance on Track

Author Image

By: TOM BRANNA

Editor

In the first quarter 2013, Lonza’s business performance was solid and in line with expectations, according to the company. While the specialty ingredients market segment showed a good performance, the pharma and biotech market segment had a slow start as anticipated. Also, performance for 2013 will be geared towards a stronger second half-year 2013, according to company executives. Lonza reiterated its 2013 EBIT guidance growth of approximately 10%.   Richard Ridinger, CEO of Lonza, said, “Ear...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters